ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag patent disease medicine

Biotech Faces Evolving Patent System
Douglas Steinberg | Mar 5, 2000 | 8 min read
Like medieval alchemists, modern biologists apply intricate, esoteric protocols to lowly matter, such as bacteria and rodents. Unlike alchemists, biologists successfully transmute these creatures into gold--disease-fighting pharmaceuticals and profits accruing from them. An indispensable ingredient in this dross-to-drug process is patent protection, which preserves monopoly and attracts investment. Unfortunately, the patent system isn't as ideal a catalyst as the chimerical philosopher's stone s
Flux and Uncertainty in the CRISPR Patent Landscape
Aggie Mika | Oct 1, 2017 | 10 min read
The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.
Opinion: Share Data for All Diseases
Elizabeth Marincola | Apr 28, 2016 | 2 min read
Along with his recent $250 million donation to cancer research, Silicon Valley entrepreneur Sean Parker emphasized the importance of data sharing.
When Science Has a Potential Payoff
Karen Pallarito(kpallarito@the-scientist.com) | Jan 16, 2005 | 8 min read
In a recent three-hour session at a Chicago hotel room, the University of Wisconsin's technology transfer office hammered out the final details of licensing deal that granted Durham, NC-based Inspire Pharmaceuticals the right to use several patents to develop glau coma treatments.
Those We Lost in 2019
Ashley Yeager | Dec 30, 2019 | 6 min read
The scientific community said goodbye to Sydney Brenner, Paul Greengard, Patricia Bath, and a number of other leading researchers this year.
Philip Leder, Who Deciphered Amino Acid Sequences, Dies
Ashley Yeager | Feb 12, 2020 | 4 min read
The Harvard Medical School researcher’s work on the genetic basis of protein coding and production led him to make groundbreaking discoveries in immunology, molecular biology, and cancer genetics.
diabetes complications type 2 biomarker blood test screen hydroxymethylation epigenetics cytosine
Blood-Based Epigenetic Screen Tests for Diabetes Complications
Katarina Zimmer | Oct 1, 2019 | 4 min read
Researchers could accurately detect life-threatening vascular complications in type 2 diabetes patients by analyzing hydroxymethylated cytosines in freely circulating DNA.
Elias A. Zerhouni
Ted Agres | Jul 7, 2002 | 4 min read
In the mid-1980s, cardiologists faced a particularly vexing problem: how to measure, accurately and noninvasively, the thickness of heart tissue as it changed over time. Elias A. Zerhouni, a young radiology professor at Johns Hopkins School of Medicine, struggled over the issue with a small team of physicists. "One day, he walked into the room with this incredible smile on his face, like you would have if you made a great molecular discovery," recalls Myron Weisfeldt, director of Hopkins' Depart
Revisiting Microarrays
Leonard Augenlicht | Oct 5, 2003 | 3 min read
Revisiting Microarrays Regarding the articles on microarrays,1-3 Pat Brown and the group at Stanford deserve great recognition for their technological innovations that led to widespread use of microarray analysis in biomedical research. However, the concept of computerized gene expression profiling, its reduction to practice, and enumeration of its potential in many areas of disease diagnosis, prognosis, drug sensitivity, and investigation of underlying mechanism has a much longer history.
2018 Top 10 Innovations
The Scientist | Dec 1, 2018 | 10+ min read
Biology happens on many levels, from ecosystems to electron transport chains. These tools may help spur discoveries at all of life's scales.

Run a Search

ADVERTISEMENT